Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine

NCT02107807 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

539

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza, Human
Flu, Human
Flu, Avian
Influenza
Influenza A Virus, H5N1 Subtype

Interventions

BIOLOGICAL: Novartis Investigational H5N1 vaccine
BIOLOGICAL: Novartis Investigational H5N1 vaccine
BIOLOGICAL: Novartis Seasonal Influenza Vaccine
BIOLOGICAL: Novartis Seasonal Influenza Vaccine

Sponsor

Seqirus

Collaborators

[object Object]